NRx Pharmaceuticals, Inc. (NasdaqCM: NRXP)
Health Care · Pharmaceuticals · US
$2.86
+0.18% today · -8.7% 1Y
NRx Pharmaceuticals, Inc. (NasdaqCM: NRXP) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $123.30M and employs 29 people.
Over the last twelve months the share price has lost 8.7%, trading between 1.62 and 5.06.
Tweenvest scores NRx Pharmaceuticals, Inc. across four factors: quality 30/100, value 69/100. Its strongest factor is value.
NRXP price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $123.30M
- Revenue (TTM)
- $3.39M
- P/E
- —
- EPS
- -0.78
- Dividend yield
- —
- Beta (5Y)
- 2.07
- 52-week high
- $5.06
- 52-week low
- $1.62
- Avg volume (3M)
- —
- Shares outstanding
- 43.26M
- Employees
- 29
- Next earnings
- —
About NRx Pharmaceuticals, Inc.
NRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm focused on developing innovative therapies for disorders of the central nervous system and critical lung diseases. Its product portfolio features ZYESAMI, an experimental medication that has successfully completed Phase IIb/III clinical trials for treating respiratory failure associated with COVID-19. Additionally, the company is advancing NRX-100 and NRX-101, a pair of oral therapeutics designed to address bipolar depression, specifically in patients exhibiting acute or sub-acute suicidal thoughts and behaviors. Established in 2015, NRx Pharmaceuticals is headquartered in Wilmington, Delaware.
- ISIN
- US6294442099
- Founded
- 2015
- Listed since
- Dec 4, 2017
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Vikram Thermo (India) LimitedBSE: 530477 | $124.99M | Rs385.75 | -4.96% |
| Orient EuroPharma Co., Ltd.TPEX: 4120 | $124.80M | NT$46.00 | -0.22% |
| Semnur Pharmaceuticals, Inc.OTCPK: SMNR | $124.31M | $0.54 | +20.00% |
| T.Man Pharmaceutical Public Company LimitedSET: TMAN | $123.98M | ฿10.40 | -0.95% |
| KUKJEON Co.,LtdKOSDAQ: A307750 | $119.47M | ₩2,975.00 | +26.06% |
| Formosa Pharmaceuticals, Inc.TWSE: 6838 | $118.52M | NT$25.10 | -0.79% |
| Hyloris Pharmaceuticals SAENXTBR: HYL | $116.63M | €4.00 | +7.53% |
| Ilsung Is Co., Ltd.KOSE: A003120 | $115.86M | ₩22,350.00 | +1.36% |
Figures last refreshed Oct 11, 2026.